Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based Conditioning
Open Access
- 7 February 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 17, 455-464
- https://doi.org/10.1016/j.omtm.2020.02.001
Abstract
No abstract availableFunding Information
- Markey Molecular Medicine Investigator
- Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research
- Endowed Chair for Stem Cell and Gene Therapy
- ’s endowment fund
- Magenta Therapeutics
- National Heart, Lung, and Blood Institute
- National Institutes of Health (P01HL122171 and R01HL147324)
- NIH/NCI Cancer Center (P30 CA015704)
This publication has 30 references indexed in Scilit:
- Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalitiesJournal of Molecular Medicine, 2012
- Pathophysiology and management of inherited bone marrow failure syndromesBlood Reviews, 2010
- Mouse models of Fanconi anemiaMutation research. Reviews in mutation research, 2009
- Hematopoietic Stem Cell Transplantation for Bone Marrow Failure Syndromes in ChildrenTransplantation and Cellular Therapy, 2009
- Efficient Transplantation via Antibody-Based Clearance of Hematopoietic Stem Cell NichesScience, 2007
- Dose translation from animal to human studies revisitedThe FASEB Journal, 2007
- Anti-CD45–mediated cytoreduction to facilitate allogeneic stem cell transplantationBlood, 2003
- Effect of procarbazine and cyclophosphamide on chromosome breakage in Fanconi anemia cells: Relevance to bone marrow transplantationCancer Genetics and Cytogenetics, 1983
- In Vitro Effect of Cyclophosphamide Metabolites on Chromosomes of Fanconi Anaemia PatientsBritish Journal of Haematology, 1980
- Bone Marrow Transplantation in Fanconi AnaemiaBritish Journal of Haematology, 1980